Conformis, Inc. to Present at the Canaccord Genuity Musculoskeletal Conference
12 mai 2021 18h10 HE
|
Conformis, Inc.
BILLERICA, Mass., May 12, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today...
Conformis Reports First Quarter 2021 Financial Results
05 mai 2021 16h05 HE
|
Conformis, Inc.
BILLERICA, Mass., May 05, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today...
Conformis Announces License Agreement with Paragon 28
19 avr. 2021 16h30 HE
|
Conformis, Inc.
BILLERICA, Mass., April 19, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that it has entered into a license agreement with Paragon 28, Inc., granting Paragon 28 a...
Conformis, Inc. to Release First Quarter 2021 Financial Results on May 5, 2021
07 avr. 2021 07h30 HE
|
Conformis, Inc.
BILLERICA, Mass., April 07, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) announced today that it will release its financial results for the first quarter ended March 31, 2021 after the...
Conformis, Inc. to Participate in Upcoming Investor Conferences
25 févr. 2021 08h00 HE
|
Conformis, Inc.
BILLERICA, Mass., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today...
Conformis, Inc. Announces Pricing of $85 Million Underwritten Offering of Common Stock
12 févr. 2021 08h30 HE
|
Conformis, Inc.
BILLERICA, Mass., Feb. 12, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (Nasdaq: CFMS) today announced it has priced an underwritten public offering of 80,952,381 shares of its common stock at an...
Conformis, Inc. Announces Proposed Public Offering of Common Stock
11 févr. 2021 16h01 HE
|
Conformis, Inc.
BILLERICA, Mass., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (Nasdaq: CFMS) today announced that it intends to offer shares of its common stock in an underwritten public offering. Conformis...
The Journey to 20,000 Total Hip Replacements
11 févr. 2021 10h30 HE
|
Intellijoint Surgical
Kitchener, ON, Feb. 11, 2021 (GLOBE NEWSWIRE) -- What started as an idea has since turned into a reality. And while the reality was never promised, the vision never wavered. “Entrepreneurs are...
Conformis, Inc. and SITES Medical Announce Development & Supply Agreement
21 janv. 2021 16h15 HE
|
Conformis, Inc.
BILLERICA, Mass. and COLUMBIA CITY, Ind., Jan. 21, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) and SITES Medical, a firm dedicated to inventing and de-risking new orthopedic medical...
Conformis, Inc. to Release Fourth Quarter and Fiscal Year 2020 Financial Results on March 3, 2021
07 janv. 2021 08h00 HE
|
Conformis, Inc.
BILLERICA, Mass., Jan. 07, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) announced today that it will release its financial results for the fourth quarter and fiscal year ended December...